课题基金 / 基金详情

PHASE I TRIAL OF SUBCUTANEOUS CALCITRIOL AND PREDNISONE IN TUMORS

PHASE I TRIAL OF SUBCUTANEOUS CALCITRIOL AND PREDNISONE IN TUMORS
皮下骨化三醇和泼尼松治疗肿瘤的 I 期试验
批准号:
5218441
负责人:
DAVID SMITH
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

DAVID SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
维生素D是一种类固醇激素,以其调节 钙和骨代谢。 维生素D的活性形式是骨化三醇 [1,25-(OH)2D3]。 流行病学证据表明,骨化三醇可能发挥 在结肠癌和前列腺癌的发展中起重要作用。 癌细胞系的临床前研究表明,骨化三醇可以杀死 然而,动物研究表明, 也会引起高钙血症。 强的松能有效降低 高钙血症 这项研究的前提是进行第一阶段; 评价骨化三醇和泼尼松联合应用治疗原发性肝癌的研究 晚期癌症患者。
英文摘要
Vitamin D is a steroid hormone best known for its activity in regulating calcium and bone metabolism. The active form of vitamin D is calcitriol [1,25-(OH)2D3]. Epidemiologic evidence suggests that calcitriol may play an important role in the development of colon and prostate cancer. Preclinical study of cancer cell lines have shown that calcitrol can kill tumor cells, however, animal studies have shown that the doses required also induce hypercalcemia. Prednisone is effective in reducing hypercalcemia. The premise of this study is to conduct a phase I;II study to evaluate the combined approach of calcitrol and prednisone in patients with advanced cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NATL HLTH ORG STRATEGIES TO PROVIDE INFO ON HEMATOLOGIC CANCERS
NATL HLTH ORG STRATEGIES TO PROVIDE INFO ON HEMATOLOGIC CANCERS
NATL HLTH ORG STRATEGIES TO PROVIDE INFO ON HEMATOLOGIC CANCERS
PHASE II CLINICAL TRIALS OF NEW CHEMOPREVENTIVE AGENTS
海外基金